Xenon Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -19.7% | -19.7% | -18.9% |
| FY2024 | -31.0% | -31.0% | -29.4% |
| FY2025 | -59.5% | -59.5% | -54.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -19.7% | -19.7% | -18.9% |
| FY2024 | -31.0% | -31.0% | -29.4% |
| FY2025 | -59.5% | -59.5% | -54.6% |